Corrected QT interval in relation to the severity of diabetic autonomic neuropathy

European Journal of Clinical Investigation

Volumn 27, Issue 12, 1997, Pages 1049-1054

  Tentolouris, N ^a   Katsilambros, N ^a   Papazachos, G ^a   Papadogiannis, D ^a   Linos, A ^a   Stamboulis, E ^a   Papageorgioub, K ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Autonomic neuropathy; Diabetes mellitus; QT interval; QTc interval; RR interval

Indexed keywords

HEMOGLOBIN A1C;

ARTICLE; AUTONOMIC NEUROPATHY; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEUROPATHY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; QT INTERVAL; RR INTERVAL; SMOKING; SYSTOLIC BLOOD PRESSURE;

EID: 0031466114     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1997.2300776.x     Document Type: Article

References (37)

1. Jervel A, Lange-Nielsen F. Congenital deaf mutism functional heart disease with prolongation of the QTc interval and sudden death. Am Heart J 1957;54:59-6.
2. Peters RW, Byington RP, Barker A, Yusuf S, BHAT Study Group. Prognostic value of prolonged ventricular repolarization following myocardial infarction: the BHAT experience. J Clin Epidemiol 1990;43:167-72.
3. Sawicki FT, Dahne R, Bender R, Berger M. Prolonged QT interval as a predictor of mortality in diabetic nephropathy. Diabetologia 1996:39:77-81.
4. Ewing DJ, Campell IW, Clarke BF. Mortality in diabetic autonomie neuropathy. Lancet 1976;i:601-3.
5. Rathman W, Ziegler P, Jahnke M, Haaster B, Cries FA. Mortality in diabetic patients with cardiovascular autonomie neuropathy. Diabetic Med 1993;10:820-4.
6. Page MMcB, Watkins PJ. Cardiorespiratory arrest in diabetic neuropathy. Lancet 1978;i:4-16.
7. Garcia-Bunuel L. Cardiorespiratory arrest in diabetic neuropathy. Lancet 1978;i:935-6.
8. Srinivasan G, Sanders G. Cardiorespiratory arrest in diabetes. Lancet 1978;i:504-50.
9. Abo K, Ishida Y, Yoshida R, Hozumi T, Ueno H, Shiotani H, Matsunaga K, Kazumi T. Torsade de pointes in NIDDM with long QT intervals. Diabetes Care 1996; 19:1010.
10. Bellavere F, Ferri M, Guarini L, Bax G, Piccoli A, Cardone C, Fedelle D. Prolonged QT period in diabetic autonomie neuropathy: a possible role in sudden cardiac death. Br Heart J 1988;59:379-83.
11. Ewing DJ, Boland O, Neilson JMM, Cho CG, Clarke BF. Autonomie neuropathy, QT interval lengthening and unexpected deaths in male diabetic patients. Acta Cardiol 1991:46:189-200.
12. Schwartz PJ, Periti M, Malliani A. The long Q-T syndrome. Am Heart J 1975;89:378-90.
13. Ahnve S, Vallin H. Influence of heart rate and inhibition of autonomie tone on the QT interval. Circulation 1982;65:435-9.
14. Schwartz PJ, Priori SG. Sympathetic nervous system and cardiac arrhythmias. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. Philadelphia: WB Saunders 1990:330-43.
15. Zipes DP. The long QT syndrome: a Rosetta stone for sympathetic related ventricular tachyarrhythmias. Circulation 1992;84:1414-19.
16. Bravenboer B, Hendriksen PH, Oey LP, Gispen W-H, Van Huffelen AC, Erkelens DW. Is the corrected QT interval a reliable indicator of the severity of diabetic autonomie neuropathy? Diabetes Care 1993:16:1249-53.
17. Gonin JM, Kadrofske MM, Schmaltz S, Bastyr EJ, Vinic AI. Corrected QT interval as diagnostic tool for assessment of cardiac autonomie neuropathy in diabetes mellitus. Diabetes Care 1990; 13:68071.
18. Veglio M, Chinaglia A, Borra M, Cavallo-Perin P. Does abnormal QT interval prolongation reflect autonomie dysfunction in diabetic patients? QTc interval measure vs. standardized tests in diabetic autonomie neuropathy. Diabetic Med 1995;12:302-6.
19. Ewing DJ, Neilson JMM. QT interval length and diabetic autonomie neuropathy. Diabetic Med 1990;7:23-6.
20. Sivieri R, Veglio M, Chinaglia A. Prevalence of QT prolongation in a type 1 diabetic population and its association with autonomie neuropathy. Diabetic Med 1993;10:920-4.
21. Ewing DJ, Clarke BF. Diagnosis and management of diabetic autonomie neuropathy. BrMed J 1982;285:9I6-18.
22. Wieling W, Van Breederode JFM, De Rijki LG, Borst E, Dunning AJ. Reflex control of heart rate in normal subjects in relation to age: a data base for cardiac vagal neuropathy. Diabetologia 1982;22: 163-6.
23. Cardone C, Painsco P, Marchetti G, Burelli F, Feruglio M, Fedele D. Cough test to assess cardiovascular autonomie neuropathy reflexes in diabetes. Diabetes Care 1990;13:719-20.
24. Ewing DJ, Clarke BF. The value of cardiovascular autonomie function tests: 10 years experience. Diabetes Care 1985;8:491-8.
25. Standardized measures in diabetic neuropathy. Consensus statement. American Diabetes Association. Diabetes Care 1995; 18: 59-78.
26. Taran LM, Szilagyi N. The duration of the electrical systole (QT) in acute rheumatic arthritis in children. Am Heart J 1947:33:14-26.
27. Bazett HC. An analysis of time-relations of electrocardiograms. Heart 1920;7:353-70.
28. Schewartz PJ, Wolf S. QT prolongation as a predictor of sudden death in patients with myocardial infarction. Circulation 1978;57: 1074-7.
29. Jermedy G, Kolbai MZ, Pogatsa G. QT interval prolongation in type 2 (non-insulin dependent) diabetic patients with cardiac autonomie neuropathy. Acta Diabetol Lat 1990;27:294-301.
30. Chambers JB, Sampson MJ, Sprigings DC, Jackson G. QT prolongation on the electrocardiogram in diabetic autonomie neuropathy. Diabetic Med 1990;7:105-10.
31. Ward DE. Prolongation of QT interval as an indicator of cardiac event. Eur Heart J 1988;9(Suppl. G): 139-44.
32. Schouten EG, Dekker JM, Meppelimk P, Kok FJ, Vanderbroucke JP, Pool J. QT interval prolongation predicts cardiovascular mortality in an apparently health population. Circulation 1991;84: 1516-23.
33. Algra A, Tijssen J, Roelandt J, Pool J, Lubsen J. QTc prolongation measured by 12 lead electrocardiogram is an independent risk factor for sudden death. Circulation 1991;83:1888-94.
34. Tesfaye S, Stevens LK, Stephenson JM et al. and the EURODIAB IDDM Study Group. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIB IDDM complications Study. Diabetologia 1996;39: 1377-84.
35. Jemedy G, Toth L, Voros P, Koltai NZ, Pogatsa G. Cardiac autonomie neuropathy and QT interval length. A follow-up study in diabetic patients. Acta Cardiol 1991;46:189-200.
36. Dekker JM, Feskens EJM, Scheuten EG, Klootwijk P, Pool J, Kromhout D. QTc duration is associated with levels of insulin and glucose tolerance. The Zutphen Elderly Study. Diabetes 1996; 45:376-80.
37. Tanaka T, Ikeda T, Ohtahara K et al. Relationship between QT interval and sympatho-parasympathetic imbalance in patients with diabetes mellitus. Diabetes 1996;45(Suppl. 2):P. 276 (Abstract 1021).